Terms: = Pancreatic cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
134 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. Downregulated circRNA_CDKN1A promotes gallbladder cancer progression through activation of the NF-κB pathway.
Hu B; Yang H; Wang Y; Cao Y; Zhou R; Yang D
Cell Biochem Funct; 2024 Mar; 42(2):e3952. PubMed ID: 38343018
[TBL] [Abstract] [Full Text] [Related]
3. cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
Deng K; Zou F; Xu J; Xu D; Luo Z
Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
[TBL] [Abstract] [Full Text] [Related]
4. Biomimetic Microenvironmental Stiffness Boosts Stemness of pancreatic Ductal Adenocarcinoma via Augmented Autophagy.
Gong T; Wu D; Pan H; Sun Z; Yao X; Wang D; Huang Y; Li X; Guo Y; Lu Y
ACS Biomater Sci Eng; 2023 Sep; 9(9):5347-5360. PubMed ID: 37561610
[TBL] [Abstract] [Full Text] [Related]
5. Blood exosome marker miRNA-30d-5p: Role and regulation mechanism in cell stemness and gemcitabine resistance of hepatocellular carcinoma.
Tang B; Xie L; Tang X; Tian J; Xiao S
Mol Cell Probes; 2023 Oct; 71():101924. PubMed ID: 37536457
[TBL] [Abstract] [Full Text] [Related]
6. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
7. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
[TBL] [Abstract] [Full Text] [Related]
8. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
[No Abstract] [Full Text] [Related]
10. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
11. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract] [Full Text] [Related]
12. Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer.
Ervin EH; French R; Chang CH; Pauklin S
Semin Cancer Biol; 2022 Dec; 87():48-83. PubMed ID: 36347438
[TBL] [Abstract] [Full Text] [Related]
13. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
[TBL] [Abstract] [Full Text] [Related]
14. pancreatic cancer Cells Induce MicroRNA Deregulation in Platelets.
Díaz-Blancas JY; Dominguez-Rosado I; Chan-Nuñez C; Melendez-Zajgla J; Maldonado V
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232741
[TBL] [Abstract] [Full Text] [Related]
15. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in pancreatic cancer Cells.
Cao X; Cao Y; Zhao H; Wang P; Zhu Z
Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
[TBL] [Abstract] [Full Text] [Related]
16. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract] [Full Text] [Related]
17. Dysregulated FOXM1 signaling in the regulation of cancer stem cells.
Sher G; Masoodi T; Patil K; Akhtar S; Kuttikrishnan S; Ahmad A; Uddin S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):107-121. PubMed ID: 35931301
[TBL] [Abstract] [Full Text] [Related]
18. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
[TBL] [Abstract] [Full Text] [Related]
19. Counterintuitive production of tumor-suppressive secretomes from oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
20. The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells.
Hassan G; Zahra MH; Seno A; Seno M
Sci Rep; 2022 Feb; 12(1):2711. PubMed ID: 35177646
[TBL] [Abstract] [Full Text] [Related]
[Next]
